Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
2000 1
2003 1
2014 1
2015 1
2016 3
2018 1
2020 1
2021 1
2022 1
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.
Pym AS, Diacon AH, Tang SJ, Conradie F, Danilovits M, Chuchottaworn C, Vasilyeva I, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, Van Baelen B, van Heeswijk RP, Dannemann B; TMC207-C209 Study Group. Pym AS, et al. Eur Respir J. 2016 Feb;47(2):564-74. doi: 10.1183/13993003.00724-2015. Epub 2015 Dec 2. Eur Respir J. 2016. PMID: 26647431 Free article. Clinical Trial.
Effectiveness of inhaled hypertonic saline application for sputum induction to improve Mycobacterium tuberculosis identification in patients with pulmonary tuberculosis.
Butov D, Feshchenko Y, Myasoedov V, Kuzhko M, Gumeniuk M, Gumeniuk G, Tkachenko A, Nataliya N, Borysova O, Butova T. Butov D, et al. Among authors: kuzhko m. Wien Med Wochenschr. 2022 Sep;172(11-12):261-267. doi: 10.1007/s10354-021-00871-5. Epub 2021 Aug 12. Wien Med Wochenschr. 2022. PMID: 34383222 Clinical Trial. English.
Effectiveness of Intravenous Isoniazid and Ethambutol Administration in Patients with Tuberculosis Meningoencephalitis and HIV Infection.
Butov D, Feshchenko Y, Kuzhko M, Gumenuik M, Yurko K, Grygorova A, Tkachenko A, Nekrasova N, Tlustova T, Kikinchuk V, Peshenko A, Butova T. Butov D, et al. Among authors: kuzhko m. Tuberc Respir Dis (Seoul). 2020 Jan;83(1):96-103. doi: 10.4046/trd.2019.0021. Tuberc Respir Dis (Seoul). 2020. PMID: 31905437 Free PMC article.
Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine.
Pedersen OS, Butova T, Kapustnyk V, Miasoiedov V, Kuzhko M, Hryshchuk L, Kornaha S, Borovok N, Raznatovska O, Fedorec A, Bogomolov A, Tkhorovskiy M, Akymenko O, Klymenko I, Kulykova O, Karpenko Z, Shapoval T, Chursina N, Kondratyuk N, Parkhomenko O, Sazonenko I, Ostrovskyy M, Makoida I, Markovtsiy L, Skryp V, Lubenko V, Hrankina N, Bondarenko L, Hlynenko V, Dahl VN, Butov D. Pedersen OS, et al. Among authors: kuzhko m. Clin Microbiol Infect. 2024 Mar;30(3):360-367. doi: 10.1016/j.cmi.2023.12.001. Epub 2023 Dec 6. Clin Microbiol Infect. 2024. PMID: 38065363 Free article.
Changes in nitric oxide synthase and nitrite and nitrate serum levels in patients with or without MDR-TB undergoing the intensive phase of anti-tuberculosis therapy.
Butov DО, Kuzhko MM, Kalmykovа IМ, Kuznetsova IМ, Butova TS, Grinishina OО, Maksimenko OА. Butov DО, et al. Among authors: kuzhko mm. Int J Mycobacteriol. 2014 Jun;3(2):139-43. doi: 10.1016/j.ijmyco.2014.02.003. Epub 2014 Mar 24. Int J Mycobacteriol. 2014. PMID: 26786336 Free article.
13 results